PRISM 3
 

Join the fight
against recurrent
C. difficile

Consider joining the PRISM 3 clinical study

 
Draft3_Stocksy_txpfedd8c01il7200_Large_1964970.png

JOIN THE FIGHT

Patient Fighting Recurrent C. Diff Infections

Recurrent C. difficile can be debilitating, isolating, and sometimes life threatening. No one should have to live in fear of another infection.

That’s why we’re enrolling PRISM 3, a clinical study of investigational capsules designed to prevent the cycles of C. difficile.


Study Features

  • An oral pill designed to repair the microbiome – no bowel prep or colonoscopy

  • Dedicated, experienced medical care

  • Free transportation and coverage of all study-related costs

Eligibility Criteria

  • 18 years or older

  • Have had more than one episode of C. difficile infection

  • Have been prescribed antibiotics for the most recent C. difficile infection

  • Do not have inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS)

-or- use the below map to contact a doctor near you

Recurrent C. difficile can be debilitating, isolating, and sometimes life threatening. No one should have to live in fear of another infection.

That’s why we’re enrolling PRISM 3, a clinical study of investigational capsules designed to prevent the cycles of C. difficile.


Study Features

  • An oral pill designed to repair the microbiome – no bowel prep or colonoscopy

  • Dedicated, experienced medical care

  • Free transportation and coverage of all study-related costs

  • Be part of the community working toward a long-term solution to recurrent C. difficile.

Eligibility Criteria

  • 18 years or older

  • Have had more than one episode of C. difficile infection

  • Have been prescribed antibiotics for the most recent C. difficile infection

  • Do not have inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS)

-or- use the below map to contact a participating doctor near you

Questions?

Share the Study

Stocksy_txpfedd8c01il7200_Large_1946904.jpg